Clinical Trials & Pharmacovigilance

Clinical trials and pharmacovigilance work hand in hand to ensure drug safety and efficacy. Clinical trials rigorously test new treatments under controlled conditions, while pharmacovigilance continues safety monitoring post-approval, detecting and assessing adverse effects. Together, they safeguard public health, optimize therapeutic strategies, and contribute to informed decision-making in healthcare.

Clinical trials and pharmacovigilance are interconnected in ensuring drug safety and effectiveness. Clinical trials test new treatments under controlled environments, while pharmacovigilance monitors these treatments post-market to identify any adverse effects. Together, they form a comprehensive approach to drug regulation and patient safety, continuously evaluating and improving therapeutic practices.

    Related Conference of Clinical Trials & Pharmacovigilance

    January 29-30, 2026

    19th World Drug Delivery Summit

    Paris, France
    February 10-11, 2026

    40th World Congress on Pharmacology and Therapeutics

    Barcelona, Spain
    February 23-24, 2026

    3rd World Congress on Biologics and Biosimilars

    London, UK
    March 23-24, 2026

    36th Annual European Pharma Congress

    London, UK
    March 24-25, 2026

    11th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    April 16-17, 2026

    19th European Biosimilars Congress

    Rome, Italy
    April 27-28, 2026

    9th European Biopharma Congress

    Paris, Aland Islands
    May 28-29, 2026

    3rd International Conference on Pharmacognosy

    Madrid, Spain
    July 27-28, 2026

    39th World Congress on Pharmacology

    Rome, Italy
    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France

    Clinical Trials & Pharmacovigilance Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in